![]() Passage Bio Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases. | ||
Founding Date | Founding Date 2018 | Founding Date 2016 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Philadelphia, US HQ | Locations Stevenage, GB HQ London, GB Ambler, US |
Employees | Employees 20 | Employees 502% increase |
Funding | ||
Total funding raised | Total funding raised $ 225.5m | Total funding raised $ 205.7m |

Gyroscope Therapeutics Holdings is an ophthalmology company.
View company